Nanoscale Res Lett. 2009 Apr 21;4(7):732-7. doi: 10.1007/s11671-009-9312-z.
The classical utilized double emulsion solvent diffusion technique for encapsulating water soluble Mitomycin C (MMC) in PLA nanoparticles suffers from low encapsulation efficiency because of the drug rapid partitioning to the external aqueous phase. In this paper, MMC loaded PLA nanoparticles were prepared by a new single emulsion solvent evaporation method, in which soybean phosphatidylcholine (SPC) was employed to improve the liposolubility of MMC by formation of MMC-SPC complex. Four main influential factors based on the results of a single-factor test, namely, PLA molecular weight, ratio of PLA to SPC (wt/wt) and MMC to SPC (wt/wt), volume ratio of oil phase to water phase, were evaluated using an orthogonal design with respect to drug entrapment efficiency. The drug release study was performed in pH 7.2 PBS at 37 degrees C with drug analysis using UV/vis spectrometer at 365 nm. MMC-PLA particles prepared by classical method were used as comparison. The formulated MMC-SPC-PLA nanoparticles under optimized condition are found to be relatively uniform in size (594 nm) with up to 94.8% of drug entrapment efficiency compared to 6.44 mum of PLA-MMC microparticles with 34.5% of drug entrapment efficiency. The release of MMC shows biphasic with an initial burst effect, followed by a cumulated drug release over 30 days is 50.17% for PLA-MMC-SPC nanoparticles, and 74.1% for PLA-MMC particles. The IR analysis of MMC-SPC complex shows that their high liposolubility may be attributed to some weak physical interaction between MMC and SPC during the formation of the complex. It is concluded that the new method is advantageous in terms of smaller size, lower size distribution, higher encapsulation yield, and longer sustained drug release in comparison to classical method.
利用经典的复乳溶剂扩散技术将水溶性丝裂霉素 C(MMC)包封于 PLA 纳米粒中,由于药物快速分配到外部水相,因此包封效率较低。在本文中,通过新的单乳液溶剂蒸发法制备了载有 MMC 的 PLA 纳米粒,其中使用大豆卵磷脂(SPC)通过形成 MMC-SPC 复合物来提高 MMC 的脂溶性。基于单因素试验结果,使用正交设计评估了四个主要影响因素,即 PLA 分子量、PLA 与 SPC(wt/wt)的比例和 MMC 与 SPC(wt/wt)的比例、油相和水相的体积比,以考察药物包封效率。在 37°C 下,在 pH 7.2 PBS 中进行药物释放研究,并用 365nm 的紫外/可见分光光度计进行药物分析。使用经典方法制备的 MMC-PLA 颗粒作为比较。在优化条件下制备的 MMC-SPC-PLA 纳米粒粒径相对均匀(594nm),药物包封效率高达 94.8%,而 PLA-MMC 微球粒径为 6.44µm,药物包封效率为 34.5%。MMC 的释放呈两相释放,初始突释效应后,PLA-MMC-SPC 纳米粒在 30 天内累积释放药物 50.17%,PLA-MMC 颗粒为 74.1%。MMC-SPC 复合物的 IR 分析表明,其高脂溶性可能归因于 MMC 和 SPC 在复合物形成过程中存在一些较弱的物理相互作用。与经典方法相比,新方法具有粒径更小、粒径分布更窄、包封率更高、药物释放更持久的优点。